NASDAQ:ANIP

Ani Pharmaceuticals Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy ANIP

*Your capital is at risk

$82.07

-1.71 (-2.04%)

At Close: Jul 10, 2026

ANI Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -79.07. In total, the insiders bought 226.72K and sold 333.49K ANIP shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-79.07
● Buy	226.72K shares
● Sell	333.49K shares
20% Buy Activity Weak Negative Correlation
Buy Signal Low Confidence Feb 26, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -79.07. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 02, 2026 Buy	Stock Option (right to buy) M-Exempt	Carey Stephen P. SVP & CFO	C-Suite Officer	3 313 Value: $164.0K
Jul 02, 2026 Sell	Common Stock S-Sale	Carey Stephen P. SVP & CFO	C-Suite Officer	3 313 Value: $284.9K
Jul 02, 2026 Buy	Common Stock M-Exempt	Carey Stephen P. SVP & CFO	C-Suite Officer	3 313 Value: $164.0K
Jun 29, 2026 Sell	Common Stock S-Sale	Carey Stephen P. SVP & CFO	C-Suite Officer	2 850 Value: $239.7K
Jun 12, 2026 Sell	Common Stock S-Sale	Cook Meredith Sr. Vp, General Counsel & Sec.	Officer	500 Value: $41.0K
Jun 08, 2026 Sell	Common Stock S-Sale	Haughey Thomas Director	Director	2 000 Value: $161.8K
Jun 05, 2026 Buy	Stock Option (right to buy) M-Exempt	Carey Stephen P. SVP & CFO	C-Suite Officer	3 312 Value: $164.0K
Jun 05, 2026 Buy	Common Stock M-Exempt	Carey Stephen P. SVP & CFO	C-Suite Officer	3 312 Value: $164.0K
Jun 05, 2026 Sell	Common Stock S-Sale	Carey Stephen P. SVP & CFO	C-Suite Officer	3 312 Value: $265.0K
May 21, 2026 Buy	Common Stock A-Award	Leonard Matthew J Director	Director	4 357 Value: $360.6K
May 21, 2026 Buy	Common Stock A-Award	Thoma Jeanne Director	Director	4 357 Value: $360.6K
May 21, 2026 Buy	Common Stock A-Award	Tannenbaum Renee P Director	Director	4 357 Value: $360.6K
May 21, 2026 Buy	Common Stock A-Award	Pera Antonio R Director	Director	4 357 Value: $360.6K
May 21, 2026 Buy	Common Stock A-Award	Haughey Thomas Director	Director	4 357 Value: $360.6K
May 13, 2026 Sell	Common Stock S-Sale	Walsh Patrick D Director	Director	10 000 Value: $806.3K
May 13, 2026 Sell	Common Stock S-Sale	Cook Meredith Sr. Vp, General Counsel & Sec.	Officer	500 Value: $39.1K
May 12, 2026 Sell	Common Stock S-Sale	Gutwerg Ori SVP, Generics	Officer	2 772 Value: $220.4K
May 12, 2026 Sell	Common Stock S-Sale	Rowland Thomas Andrew SVP, Head - Established Brands	Officer	459 Value: $36.4K
May 11, 2026 Sell	Common Stock S-Sale	Lalwani Nikhil President & CEO	CEO / President	55 000 Value: $4.27M
May 11, 2026 Sell	Common Stock S-Sale	Walsh Patrick D Director	Director	3 973 Value: $320.8K
Apr 13, 2026 Sell	Common Stock S-Sale	Cook Meredith Sr. Vp, General Counsel & Sec.	Officer	500 Value: $39.0K
Mar 13, 2026 Sell	Common Stock S-Sale	Mutz Christopher Head Of Rare Disease	Officer	3 162 Value: $226.5K
Mar 13, 2026 Sell	Common Stock S-Sale	Cook Meredith Sr. Vp, General Counsel & Sec.	Officer	500 Value: $36.3K
Mar 11, 2026 Sell	Common Stock S-Sale	Rowland Thomas Andrew SVP, Head - Established Brands	Officer	4 772 Value: $357.5K
Mar 09, 2026 Sell	Common Stock S-Sale	Davis Krista SVP, Chief Hr Officer	Officer	5 087 Value: $377.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ANI PHARMACEUTICALS

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development a...

Read Full Profile Here